Treatment of bacterial infections induced by Gram-negative and Gram-positive amoxicillin resistant microorganisms whose resistance is caused by β-lactamases which however are sensitive to the combination of amoxicillin and clavulanic acid.
Amoxicillin/clavulanic acid powder for oral suspension is suitable for treatment of the following indications when or likely to be due to susceptible organisms (see Pharmacology: Pharmacodynamics under Actions): Infections of the upper respiratory tract (including ear-nose-throat), in particular sinusitis, otitis media, recurrent tonsillitis.
Infections of the lower respiratory tract, in particular acute exacerbations of chronic bronchitis and bronchopneumonia.
Genital and urinary tract infections.
Infections of the skin and soft tissues.
Considerations should be given to official local guidance on the appropriate use of antibacterial agents.